MedTrace Logo

Evaluating of the Impact of Micronutrient Interventions Among Adolescents in Mozambique

NCT06815315 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 490

Last updated 2025-02-07

No results posted yet for this study

Summary

This purpose of this study is to assess effects of iron and folic acid supplementation and multiple micronutrient supplementation on anemia status and the impact of a nutrition curriculum on diet diversity and anemia knowledge among adolescent girls.

Conditions

Interventions

DIETARY_SUPPLEMENT

Multiple micronutrient supplementation

The multiple micronutrient supplementation composition follows the United Nations International Multiple Micronutrient Antenatal Preparation. Each MMS tablet contains 15 micronutrients, including iron (30mg), folic acid (400 mcg), Vit A, Retinol (800 RE), vit D (200 IU), vit E (10 mg), vit C (70 mg), vit B1 (1.4 mg), vit B2 (1.4 mg), vit B6 (1.9 mg), vit B12 (2.6 mcg), niacin (18 mg), zinc (15 mg), copper (2 mg), iodine (150 mcg), selenium (65 mcg) and is consumed daily.

DIETARY_SUPPLEMENT

Iron Folic Acid Supplementation

One IFAS tablet contains Iron (60 mg) and Folic Acid (2800 μg) and is taken weekly.

BEHAVIORAL

Adolescent Nutrition Curriculum

The Adolescent Nutrition Curriculum includes five modules focused on promoting healthy behaviors to enhance nutrition, with an emphasis on consuming iron-rich foods.

Sponsors & Collaborators

  • World Vision US

    lead OTHER

Principal Investigators

  • Sarah A Bauler, DrPH(c) · World Vision International

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-09-30
Completion
2024-12-31

Countries

  • Mozambique

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06815315 on ClinicalTrials.gov